REZUMAT
NAFLD este considerat un component al sindromului metabolic, avnd ca factori majori de risc obezitatea i
insulinorezistena.
IMT carotidian este un marker al modificrilor precoce la nivelul peretelui arterial, iar pacienii cu NAFLD sunt
la risc crescut de a prezena IMT peste valorile normale i deci risc crescut pentru bolile cardiovasculare.
Determinarea IMT carotidian prin ultrasonografie Doppler, modul B la pacienii cu ficat gras poate aduce
beneficii n prevenia primar i n decizia de a trata bolile cardiovasculare existente, dar nediagnosticate.
Cuvinte cheie: NAFLD, sindrom metabolic, boal cardiovascular (risc).
ABSTRACT
NAFLD is considered to be a part of the metabolic syndrome, having major risk factors like: obesity and
insulinoresistance.
Carotidian IMT is a marker of early changes at the arterial wall and patients with NAFLD are at high risk to
present an IMT with raised values, thus a higher risk for cardiovascular diseases.
Determination of carotidian IMT by Doppler module B at patients with fatty liver can bring positive outcome in
the primary prevention and in the decision to treat the cardiovascular diseases undiagnosed yet.
Cuvinte cheie: NAFLD, metabolicsyndrome, cardiovascular disease (risk).
Abrevieri:
NAFL(D) = Non Alcohoolic Fatty Liver (Disease)
NASH = Non Alcohoolic Steato Hepatitis
AVC
= Accident Vascular Cerebral
IMT
= Intim Medie Thickness (carotide)
HTA
= Hipertensiune arterial
Adres de coresponden:
Dr. Laura Diana Lupu, Spitalul Universitar de Urgen, Splaiul Independenei, Nr. 169, Bucureti
37
38
Tabelul 1. Stadiile NAFLD (2)
39
Figura 2
40
BIBLIOGRAFIE
1.
2.
3.
4.
5.
6.
7.
41
19. Lind L Circulating markers of inflammation and atherosclerosis,
Atherosclerosis 2003; 169: 203-214.
20. Matsuzawa Y, Kihara S et al Adiponectin and metabolic
syndrome, Arterioscler.Thromb.Vasc.Biol.2004; 24: 29-33.
21. Hui JM, Hodge A et al Beyond insulin resistance in NASH: TNFalpha or adiponectin? Hepatoly 2004; 40: 46-54.
22. Musso G, Gambino R et al Adipokines in NASH: post-prandial
lipid metabolism as a link between adiponectin and liver disease.
Hepatology 2005; 42: 1175-1183.
23. OLeary DH, Polak JF et al Distribution and correlates of
sonographically detected carotid artery disease in the Cardiovascular
Health Study. The CHS Collaborative Research Group.. Stroke
1992; 23: 1752-1760.
24. Villanova N, Bugianesi E et al Endothelial dysfunction and
cardiovascular risk profile in nonalcoholic fatty liver disease.
Hepatology 2005; 42: 473-480.